The Importance of Insulin Action in the Brain for the Immune System During Physical Activity
Launched by UNIVERSITY OF ULM · Aug 8, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how insulin works in the brain and its effects on the immune system during physical activity. Researchers want to understand how insulin delivery, given as a nasal spray, compares to a placebo (a spray with no active ingredients) on days when participants exercise on a bicycle. The goal is to see if insulin in the brain helps with immune responses during physical activity.
To be eligible for this trial, participants should be between 65 and 74 years old, have a body mass index (BMI) of less than 24, and not have any major health issues. They should also not smoke, abuse drugs or alcohol, or have low hemoglobin levels, which are important for overall health. If you decide to participate, you can expect to take part in exercise tests while receiving either the insulin spray or the placebo, helping researchers learn more about how insulin affects our body during exercise.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \< 24 kg/m2
- • no known primary diseases
- • hormonal contraception with a single-phase preparation
- Exclusion Criteria:
- • Alcohol or drug abuse
- • Smoking
- • At screening: Hb \< 12 g/dl for women and Hb \< 14 g/dl for men
- • Any (clinical) condition that would endanger participant's safety or question scientific success according to a physician's opinion.
About University Of Ulm
The University of Ulm is a leading academic institution located in Germany, renowned for its commitment to cutting-edge research and innovation in the fields of medicine and health sciences. As a clinical trial sponsor, the university leverages its robust network of researchers and clinical experts to advance medical knowledge and improve patient outcomes. With a focus on interdisciplinary collaboration, the University of Ulm conducts comprehensive clinical studies that adhere to the highest ethical standards and regulatory guidelines. Through its research initiatives, the university aims to contribute significantly to the development of new therapies and treatment modalities, fostering a deeper understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ulm, , Germany
Patients applied
Trial Officials
Martin Heni, MD
Principal Investigator
University of Ulm
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported